Hematopoietic and therapeutic properties of bestatin in normal and myelosuppressed mice.

Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53

Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09

A small, nonpeptidyl mimic of granulocyte-colony-stimulating factor [see commetns]. Science (1998) 1.86

Induction of prostaglandin E synthesis in normal and neoplastic macrophages: role for colony-stimulating factor(s) distinct from effects on myeloid progenitor cell proliferation. Proc Natl Acad Sci U S A (1979) 1.63

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis. Blood (2001) 1.61

CK beta-11/macrophage inflammatory protein-3 beta/EBI1-ligand chemokine is an efficacious chemoattractant for T and B cells. J Immunol (1998) 1.60

Role of aminopeptidase N (CD13) in tumor-cell invasion and extracellular matrix degradation. Int J Cancer (1993) 1.52

Role for monocyte-macrophage-derived colony-stimulating factor and prostaglandin E in the positive and negative feedback control of myeloid stem cell proliferation. Blood (1978) 1.52

Regulation of macrophage and granulocyte proliferation. Specificities of prostaglandin E and lactoferrin. J Exp Med (1979) 1.51

High-performance liquid chromatographic assay of serum glycated albumin. Diabetologia (1988) 1.47

Prostaglandins and the immune response. Life Sci (1977) 1.46

Differential chemotactic behavior of developing T cells in response to thymic chemokines. Blood (1998) 1.42

Rapid mobilization of murine hematopoietic stem cells with enhanced engraftment properties and evaluation of hematopoietic progenitor cell mobilization in rhesus monkeys by a single injection of SB-251353, a specific truncated form of the human CXC chemokine GRObeta. Blood (2001) 1.16

Relationship between oxygen sensitivity and oxygen metabolism of Bifidobacterium species. J Dairy Sci (1992) 1.14

Differential proliferative effects of transforming growth factor-beta on human hematopoietic progenitor cells. J Immunol (1988) 1.11

Eicosanoid regulation of hematopoiesis and hematopoietic stem and progenitor trafficking. Leukemia (2010) 1.09

Effects of CC, CXC, C, and CX3C chemokines on proliferation of myeloid progenitor cells, and insights into SDF-1-induced chemotaxis of progenitors. Ann N Y Acad Sci (1999) 1.08

Gastric small-cell undifferentiated carcinoma with adeno and squamous cell carcinoma components. Acta Pathol Jpn (1985) 1.05

CCR7 ligands, SLC/6Ckine/Exodus2/TCA4 and CKbeta-11/MIP-3beta/ELC, are chemoattractants for CD56(+)CD16(-) NK cells and late stage lymphoid progenitors. Cell Immunol (1999) 1.04

Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E. J Clin Invest (1982) 1.04

FR901483, a novel immunosuppressant isolated from Cladobotryum sp. No. 11231. Taxonomy of the producing organism, fermentation, isolation, physico-chemical properties and biological activities. J Antibiot (Tokyo) (1996) 1.03

Protective, restorative, and therapeutic properties of recombinant human IL-1 in rodent models. J Immunol (1988) 1.01

Monocyte-conditioned medium and interleukin 1 induce granulocyte-macrophage colony-stimulating factor production in the adherent cell layer of murine bone marrow cultures. Exp Hematol (1986) 0.99

Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E. Exp Hematol (1984) 0.98

Regulation of human myelopoiesis by prostaglandin E and lactoferrin. Cell Tissue Kinet (1981) 0.98

In vivo modulation of murine myelopoiesis following intravenous administration of prostaglandin E2. Blood (1983) 0.98

Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E. Blood (1982) 0.97

Indomethacin enhancement of spleen-cell responsiveness to mitogen stimulation in tumorous mice. Int J Cancer (1976) 0.97

Suppression of tissue graft rejection by spergualin. J Antibiot (Tokyo) (1985) 0.97

Transition of starving Dictyostelium cells to differentiation phase at a particular position of the cell cycle. Differentiation (1989) 0.96

Increased prostaglandin synthesis by macrophages from tumor-bearing mice. J Immunol (1979) 0.94

Role of glycosylation in the H-2-restricted cytolysis of virus-infected cells. Eur J Immunol (1981) 0.92

Nocturnal blood pressure and silent cerebrovascular lesions in elderly Japanese. Stroke (1996) 0.92

[A case of arteriovenous malformation with cyst formation]. No Shinkei Geka (1993) 0.90

Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Exp Hematol (1989) 0.90

Macrophage-inflammatory protein-3 beta/EBI1-ligand chemokine/CK beta-11, a CC chemokine, is a chemoattractant with a specificity for macrophage progenitors among myeloid progenitor cells. J Immunol (1998) 0.90

Cerebral angiographic changes on serial examination of a patient with migraine. Neuroradiology (1983) 0.90

Cell-based and animal models for hepatitis B and C viruses. Antivir Chem Chemother (1999) 0.90

Expansion of bone marrow neutrophils following G-CSF administration in mice results in osteolineage cell apoptosis and mobilization of hematopoietic stem and progenitor cells. Leukemia (2012) 0.90

Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. J Antibiot (Tokyo) (1987) 0.89

Identification of milk proteins enhancing the antimicrobial activity of lactoferrin and lactoferricin. J Dairy Sci (2013) 0.88

Prostaglandin E acts at two levels to enhance colony formation in vitro by erythroid (BFU-E) progenitor cells. Exp Hematol (1987) 0.87

Immunosuppressive activities of 15-deoxyspergualin in animals. J Antibiot (Tokyo) (1987) 0.87

Inhibition of tumor cell invasion by ubenimex (bestatin) in vitro. Jpn J Cancer Res (1989) 0.86

Multiple lymphokine production by a phorbol ester-stimulated mouse thymoma: relationship to cell cycle events. J Natl Cancer Inst (1983) 0.86

Effect of spergualin in autoimmune disease mice. J Antibiot (Tokyo) (1987) 0.86

Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines. Leukemia (1999) 0.86

Heterogeneity among resident murine peritoneal macrophages: separation and functional characterization of monocytoid cells producing granulocyte-macrophage colony-stimulating factor (GM-CSF) and responding to regulation by lactoferrin. J Immunol (1981) 0.85

The role of marrow accessory cell populations in the augmentation of human erythroid progenitor cell (BFU-E) proliferation by prostaglandin E. Leuk Res (1989) 0.85

Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E. Blood (1986) 0.85

In vivo modulation of myelopoiesis by prostaglandin E2. IV. Prostaglandin E2 induction of myelopoietic inhibitory activity. J Immunol (1988) 0.85

Inhibition of tumor invasion and extracellular matrix degradation by ubenimex (bestatin). Clin Exp Metastasis (1992) 0.85

In vivo modulation of myelopoiesis by prostaglandin E2. II. Inhibition of granulocyte-monocyte progenitor cell (CFU-GM) cell-cycle rate. Exp Hematol (1987) 0.84

Leucinostatins, peptide mycotoxins produced by Paecilomyces lilacinus and their possible roles in fungal infection. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.84

Cell cycle specific effects of deferoxamine on human and murine hematopoietic progenitor cells. Cancer Res (1988) 0.83

Antiproliferative constituents in the plants 7. Leaves of Clerodendron bungei and leaves and bark of C. trichotomum. Biol Pharm Bull (2001) 0.83

Mucormycosis in diabetic ketoacidosis. Role of unbound iron binding capacity of transferrin. Acta Pathol Jpn (1986) 0.83

A new fluorometric method for the determination of spermidine and spermine in tissues by thin layer chromatography. Anal Biochem (1975) 0.83

Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro. Jpn J Cancer Res (1996) 0.83

Changes in prostacyclin, thromboxane A2 and F2-isoprostanes, and influence of eicosapentaenoic acid and antiplatelet agents in patients with hypertension and hyperlipidemia. Immunopharmacology (1999) 0.82

Difference in urinary LTE4 and 11-dehydro-TXB2 excretion in asthmatic patients. Prostaglandins Other Lipid Mediat (2000) 0.82

Lactoferrin: affinity purification from human milk and polymorphonuclear neutrophils using monoclonal antibody (II 2C) to human lactoferrin, development of an immunoradiometric assay using II 2C, and myelopoietic regulation and receptor-binding characteristics. Blood Cells (1986) 0.82

Liquid chromatography combined with thermospray and continuous-flow fast atom bombardment mass spectrometry of glycosides in crude plant extracts. J Chromatogr A (1995) 0.82

Abnormal responsiveness of granulocyte-macrophage committed colony-forming cells from patients with chronic myeloid leukemia to inhibition by prostaglandin E1. Cancer Res (1980) 0.82

Plasma hormone and metabolite concentrations involved in the somatotropic axis of Japanese Black heifers in association with growth hormone gene polymorphism. Domest Anim Endocrinol (2009) 0.81

Oleasides; novel cardenolides with an unusual framework in Nerium (Nerium 10). Chem Pharm Bull (Tokyo) (1979) 0.81

Detection of luxol-fast-blue positive cells in human promyelocytic leukemia cell line HL-60. Exp Hematol (1981) 0.81

Experimental candidiasis in iron overload. Mycopathologia (1985) 0.81

Ocular lesions in chickens inoculated with Escherichia coli. Can J Vet Res (1987) 0.81

Restoration of responsiveness of chronic myeloid leukemia granulocyte-macrophage colony-forming cells to growth regulation in vitro following preincubation with prostaglandin E. Blood (1983) 0.81

Antisense-mediated regulation of Annexin VII gene expression during the transition from growth to differentiation in Dictyostelium discoideum. Gene (1997) 0.81

Lingual necrosis secondary to mucormycosis. Br J Oral Maxillofac Surg (2011) 0.81

High-performance affinity chromatography system for the rapid, efficient assay of glycated albumin. J Chromatogr (1992) 0.81

Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. IV. Fluorometric method for the determination of D-glucaric acid in serum. Chem Pharm Bull (Tokyo) (1972) 0.81

Correlation between lymphocyte responses and immediate hypersensitivity to purified allergens. J Allergy Clin Immunol (1980) 0.80

Augmentation of death ligand-induced apoptosis by aminopeptidase inhibitors in human solid tumor cell lines. Int J Cancer (2001) 0.80

Deoxyspergualin, a novel immunosuppressant, markedly inhibits human mixed lymphocyte reaction and cytotoxic T-lymphocyte activity in vitro. Int J Immunopharmacol (1992) 0.80

Suppression of humoral immunity in dogs by 15-deoxyspergualin. J Antibiot (Tokyo) (1987) 0.80

5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway. Am J Physiol Cell Physiol (2015) 0.80

In vitro immunosuppressive properties of spergualins to murine T cell response. J Antibiot (Tokyo) (1989) 0.80

Growth inhibitory effect of Hcc-1/CIP29 is associated with induction of apoptosis, not just with G2/M arrest. Cell Mol Life Sci (2005) 0.80

The relative value of glycated albumin, hemoglobin A1c and fructosamine when screening for diabetes mellitus. Diabetes Res Clin Pract (1989) 0.80

Renal actinomycosis associated with a duodenorenal fistula caused by foreign body. Acta Pathol Jpn (1984) 0.79

Signaling induced by erythropoietin and stem cell factor in UT-7/Epo cells: transient versus sustained proliferation. Stem Cells (2000) 0.79

Intestinal mucormycosis in a hemodialysis patient treated with desferrioxamine. Acta Pathol Jpn (1991) 0.79

Identification of unique truncated KC/GRO beta chemokines with potent hematopoietic and anti-infective activities. J Immunol (2000) 0.79

Purification and characterization of a ubenimex (Bestatin)-sensitive aminopeptidase B-like enzyme from K562 human chronic myeloid leukemia cells. FEBS Lett (1994) 0.79

Protective, restorative, and therapeutic properties of recombinant colony-stimulating factors. Blood (1989) 0.79

Biological activities of deoxyspergualin in autoimmune disease mice. J Antibiot (Tokyo) (1988) 0.79

Genetically obese mice: resistance to metastasis of B16 melanoma and enhanced T-lymphocyte mitogenic responses. Science (1983) 0.79

Effect of bestatin on syngeneic tumors in mice. Gan (1984) 0.79

Deoxyspergualin directly suppresses antibody formation in vivo and in vitro. J Antibiot (Tokyo) (1990) 0.78

Preclinical approaches to the treatment of metastatic disease: therapeutic properties of rH TNF, rM IFN-gamma, and rH IL-2. Drugs Exp Clin Res (1987) 0.78

Specific inhibitory activity against granulocyte-progenitor cells produced by non-T lymphocytes from patients with neutropenia. Exp Hematol (1980) 0.78

Enhancement of interleukin 1 and interleukin 2 releases by ubenimex. J Antibiot (Tokyo) (1987) 0.78

Multiple primary malignant fibrous histiocytoma of the stomach and small intestine. Acta Pathol Jpn (1985) 0.78

[A family of hemoglobinopathy detected with high performance liquid chromatography]. Rinsho Byori (1987) 0.78

SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells. Blood Cells Mol Dis (2000) 0.78